Regeneron Pharmaceuticals (REGN) Acquisitions (2023 - 2025)

Regeneron Pharmaceuticals' Acquisitions history runs 3 years deep, the most recent figure standing at $300000.0 for Q4 2025.

• In Q4 2025, Acquisitions fell 97.39% year-over-year to $300000.0; the TTM figure through Dec 2025 stood at $14.8 million (down 77.71% YoY), while the FY2025 annual figure was $3.3 million, down 80.0% from the prior year.
• Acquisitions for Q4 2025 stood at $300000.0, down from $3.0 million in the prior quarter.
• The five-year high for Acquisitions was $51.1 million in Q3 2023, with the low at $300000.0 in Q4 2025.
• The 3-year median for Acquisitions is $3.8 million (2023), against an average of $13.9 million.
• The sharpest annual moves came in 2024 and 2025: Acquisitions jumped 202.63% in 2024, then tumbled 97.39% in 2025.
• Regeneron Pharmaceuticals' Acquisitions stood at $3.8 million in 2023, then surged by 202.63% to $11.5 million in 2024, then sank by 97.39% to $300000.0 in 2025.
• Business Quant data shows REGN's Acquisitions at $300000.0 in Q4 2025, $3.0 million in Q3 2025, and $11.5 million in Q4 2024.